---
title: Publications
---

(Under construction)

## 1999

- Antman, E. M., Giugliano, R. P., Gibson, C. M., McCabe, C. H.,
Coussement, P., Kleiman, N. S., Vahanian, A., Adgey, A. J., Menown, I.,
Rupprecht, H.-J., et al. (1999). Abciximab facilitates the rate and
extent of thrombolysis: Results of the thrombolysis in myocardial
infarction (TIMI) 14 trial. *Circulation*, *99*(21), 2720–2732.

## 1997

- Capture Investigators and others. (1997). Randomized
placebo-controlled trial of abciximab before and during coronary
intervention in refractory angina: The CAPTURE study. *Lancet*, *349*,
1429–1435.

- Epilog Investigators. (1997). Platelet glycoprotein IIb/IIIa
receptor blockade and low-dose heparin during percutaneous coronary
revascularization. *New England Journal of Medicine*, *336*(24),
1689–1697.

- Topol, E. J., Ferguson, J. J., Weisman, H. F., Tcheng, J. E., Ellis,
S. G., Kleiman, N. S., Ivanhoe, R. J., Wang, A. L., Miller, D. P.,
Anderson, K. M., et al. (1997). Long-term protection from myocardial
ischemic events in a randomized trial of brief integrin *β*3
blockade with percutaneous coronary intervention. *JAMA*, *278*(6),
479–484.

## 1994

- Epic Investigators. (1994). Use of a monoclonal antibody directed
against the platelet glycoprotein IIb/IIIa receptor in high-risk
coronary angioplasty. *New England Journal of Medicine*, *330*(14),
956–961.

- Topol, E., Califf, R., Weisman, H., Ellis, S., Tcheng, J., Worley,
S., Ivanhoe, R., George, B., Fintel, D., Weston, M., et al. (1994).
Randomised trial of coronary intervention with antibody against platelet
IIb/IIIa iritegrin for reduction of clinical restenosis: Results at six
months. *The Lancet*, *343*(8902), 881–886.

## 1993

- Ho, K., Anderson, K. M., Kannel, W. B., Grossman, W., & Levy, D.
(1993). Survival after the onset of congestive heart failure in
framingham heart study subjects. *Circulation*, *88*(1), 107–115.

## 1992

- Castelli, W. P., Anderson, K., Wilson, P. W., & Levy, D. (1992).
Lipids and risk of coronary heart disease the framingham study. *Annals
of Epidemiology*, *2*(1-2), 23–28.

## 1991

- Anderson, K. M., Odell, P. M., Wilson, P. W., & Kannel, W. B.
(1991). Cardiovascular disease risk profiles. *American Heart Journal*,
*121*(1), 293–298.

- Anderson, K. M., Wilson, P., Odell, P. M., & Kannel, W. B. (1991).
An updated coronary risk profile. A statement for health professionals.
*Circulation*, *83*(1), 356–362.

- Galderisi, M., Anderson, K. M., Wilson, P. W., & Levy, D. (1991).
Echocardiographic evidence for the existence of a distinct diabetic
cardiomyopathy (the framingham heart study). *The American Journal of
Cardiology*, *68*(1), 85–89.

- Lauer, M. S., Anderson, K. M., Kannel, W. B., & Levy, D. (1991).
The impact of obesity on left ventricular mass and geometry: The
framingham heart study. *JAMA*, *266*(2), 231–236.

## 1990

- D’Agostino, R. B., Lee, M.-L., Belanger, A. J., Cupples, L. A.,
Anderson, K., & Kannel, W. B. (1990). Relation of pooled logistic
regression to time dependent cox regression analysis: The framingham
heart study. *Statistics in Medicine*, *9*(12), 1501–1515.

- Levy, D., Labib, S. B., Anderson, K. M., Christiansen, J. C.,
Kannel, W. B., & Castelli, W. P. (1990). Determinants of sensitivity and
specificity of electrocardiographic criteria for left ventricular
hypertrophy. *Circulation*, *81*(3), 815–820.

- Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., &
Castelli, W. P. (1990). Prognostic implications of echocardiographically
determined left ventricular mass in the framingham heart study. *New
England Journal of Medicine*, *322*(22), 1561–1566.

## 1988

- LEVY, D., ANDERSON, K. M., SAVAGE, D. D., KANNEL, W. B.,
CHRISTIANSEN, J. C., & Castelli, W. P. (1988). Echocardiographically
detected left ventricular hypertrophy: Prevalence and risk factors: The
framingham heart study. *Annals of Internal Medicine*, *108*(1), 7–13.

## 1987

- Anderson, K. M., Castelli, W. P., & Levy, D. (1987). Cholesterol
and mortality: 30 years of follow-up from the framingham study. *JAMA*,
*257*(16), 2176–2180.

- Levy, D., Savage, D. D., Garrison, R. J., Anderson, K. M., Kannel,
W. B., & Castelli, W. P. (1987). Echocardiographic criteria for left
ventricular hypertrophy: The framingham heart study. *The American
Journal of Cardiology*, *59*(9), 956–960.

- Levy, D., Anderson, K. M., Savage, D. D., Balkus, S. A., Kannel, W.
B., & Castelli, W. P. (1987). Risk of ventricular arrhythmias in left
ventricular hypertrophy: The framingham heart study. *The American
Journal of Cardiology*, *60*(7), 560–565.

## 1986

- Castelli, W. P., & Anderson, K. (1986). A population at risk:
Prevalence of high cholesterol levels in hypertensive patients in the
framingham study. *The American Journal of Medicine*, *80*(2), 23–32.
